跳至主要内容
临床试验/NCT03137472
NCT03137472招募中不适用

Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)

Stanford University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年4月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Change in Pain

研究概览

简要总结

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Single, blinding of participant

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-70
  • Diagnosis of CRPS (complex regional pain syndrome) for at least 3 months
  • Average pain level reported on Numerical Rating Scale meets entry criteria
  • Ability to perform the experimental task and procedures.

排除标准

  • MRI contraindication (metal implants or devices, claustrophobia)
  • TMS Contraindication (eg metal implant or devices near the site of stimulation)
  • History of epilepsy
  • History of a psychological or psychiatric disorder that would interfere with study procedures, at the discretion of the researcher.
  • Neurologic illness that would interfere with brain integrity
  • Current medical condition or medication use that would interfere with study procedures or data integrity, at the discretion of the researcher.
  • Currently pregnant or planning to become pregnant.
  • On going legal action or disability claim.

研究组 & 干预措施

Sham Treatment

Sham Comparator

Participants will receive active TMS in a non-target area once daily for two days

干预措施: Transcranial Magnetic Stimulation (TMS) (Device)

Active Treatment

Experimental

Participants will receive active TMS in the target area once daily for two days

干预措施: Transcranial Magnetic Stimulation (TMS) (Device)

结局指标

主要结局

Change in Pain

时间窗: 1 week follow-up compared to baseline

Decrease in CRPS-related Pain Ratings

Duration of Pain Relief

时间窗: Duration from last treatment until pain returns - up to an estimate of 6 months

Duration of decreased CRPS-related pain ratings, measured as a length of time until pain returns for two consecutive weeks

次要结局

  • Change in Pain-related Symptomology(Duration from last treatment until pain returns - up to an estimate of 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sean Mackey

Chief, Division of Pain Medicine

Stanford University

研究点 (2)

Loading locations...

相似试验